AIDS and Behavior

, Volume 17, Issue 6, pp 2109–2113 | Cite as

We Can Do More Than Just Sell the Test: Pharmacist Perspectives About Over-the-Counter Rapid HIV Tests

  • Beth E. Meyerson
  • Priscilla T. Ryder
  • Christiana von Hippel
  • Kelsey Coy
Original Paper


Pharmacist attitudes about the over-the-counter (OTC) sale of HIV rapid tests in pharmacies were explored through interviews conducted among 17 licensed community pharmacists in a Midwestern, moderate HIV incidence state between May and September 2012. Participants recognized that OTC rapid HIV tests would increase the number of people aware of their HIV status. Concerns included linkage to care and results consultation for those who test HIV-positive. Point of sale was identified as an opportunity for consultation about the test and to establish a relationship for future discussion about results and linkage to care. Pharmacists could provide initial test consultation or information, and consultation about the test results in order to provide post diagnosis support and facilitate linkage to care.


HIV testing HIV rapid testing Over the counter tests Pharmacy based public health HIV testing in pharmacies 


Las actitudes de los farmacéuticos sobre el over-the-counter (OTC) venta de las pruebas rápidas del VIH en farmacias se exploró a través de entrevistas entre los 17 farmacéuticos comunitarios con licencia en un estado del Midwestern en Estados Unidos, moderado incidencia del VIH entre Mayo y Septiembre de 2012. Los participantes reconocieron que OTC pruebas rápidas de VIH aumentaría el número de personas que conocen su estado serológico. Las preocupaciones incluyen la vinculación con cuidado y consulta los resultados para los que el resultado es VIH-positivo. Point of sale de venta fue identificado como una oportunidad de consulta sobre la prueba y establecer una relación para un discussion futuro sobre los resultados y la vinculación a la atención. Los farmacéuticos podría ofrecer consulta inicial de prueba o información y consulta sobre los resultados de la prueba con el fin de ofrecer apoyo después de diagnóstico y facilitar la vinculación a la atención.


  1. 1.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRefGoogle Scholar
  2. 2.
    U.S. Centers for Disease Control and Prevention. (2011). HIV in the United States [Data File]. Retrieved from accessed November 1, 2012.
  3. 3.
    U.S. Centers for Disease Control and Prevention. Late HIV Testing—34 States, 1996-2005. MMWR 2009; 58(24), 661-665.Google Scholar
  4. 4.
    U.S. Food and Drug Administration. News Release July 3, 2012. FDA Approves first over-the-counter home-use rapid HIV test. accessed November 1, 2012.
  5. 5.
    U.S. Centers for Disease Control and Prevention. Vital Signs: HIV Prevention Through Care and Treatment- United States. MMWR. 2011; 60(47):1618-1623.Google Scholar
  6. 6.
    Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedCrossRefGoogle Scholar
  7. 7.
    Meyerson BE, Ryder PT, Smith C. Achieving pharmacy based public health: call for public health engagement. Public Health Reports. 2013;128(3):May/June.Google Scholar
  8. 8.
    Agomo C. The role of community pharmacists in public health: a scoping review of the literature. J Pharmaceutical Health Services Research. 2012;3:25–33.CrossRefGoogle Scholar
  9. 9.
    Abramowitz PW. The evolution and metamorphosis of the pharmacy practice model. AM J Health System Pharmacy. 2009;66:1437–46.CrossRefGoogle Scholar
  10. 10.
    Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc (Wash DC). 2006;46:168–82.Google Scholar
  11. 11.
    Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc (Wash). 2000;40:252–6.Google Scholar
  12. 12.
    Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes and hospitals. Vaccine. 1998;16(18):1705–10.PubMedCrossRefGoogle Scholar
  13. 13.
    Chandra A, Malcolm N, Fetters M. Practicing health promotion through pharmacy counseling activities. Health Promot Pract. 2003;4:64–71.PubMedCrossRefGoogle Scholar
  14. 14.
    Letassy N, Dennis V, Lyons TJ, et al. Know your diabetes risk project: student pharmacists educating adults about diabetes risk in a community pharmacy setting. J Am Pharm Assoc. 2010;50:188–94.CrossRefGoogle Scholar
  15. 15.
    Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012;52:507–14.CrossRefGoogle Scholar
  16. 16.
    Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporosis In. 2011;22(10):2587–96.CrossRefGoogle Scholar
  17. 17.
    Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo B. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care and STDs. 2012;26(9):526–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for medi-cal beneficiaries. J Manag Care Pharmacy. 2009;15(1):32–41.Google Scholar
  19. 19.
    Bunting BA, Smith BH, Rutherford SE. The Ashville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.CrossRefGoogle Scholar
  20. 20.
    Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist initiated screening and patient education program for osteoporosis: randomized controlled trial. Osteoporos In. 2010;21:391–8.CrossRefGoogle Scholar
  21. 21.
    Amesty S, Blaney S, Crawford ND, Rivera AV, Fuller C. Pharmacy staff characteristics associated with support for pharmacy-based HIV testing. AIDS Patient Care and STDs. 2012;26(9):526–31. doi:10.1089/apc.2012.0189.CrossRefGoogle Scholar
  22. 22.
    Lutnik A, Case P, Kral AH. Injection Drug Users’ Perspectives on Placing HIV Prevention and other clinical services in pharmacy settings. J Urb Health Bull NY Acad Med. 2012;89(2):354–64.CrossRefGoogle Scholar
  23. 23.
    Ryder PT, Meyerson BE, Coy KC, Von Hippel CD. (in review) Rapid HIV Testing in Community Pharmacies: Perspectives from Community Pharmacists.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Beth E. Meyerson
    • 1
  • Priscilla T. Ryder
    • 2
  • Christiana von Hippel
    • 1
  • Kelsey Coy
    • 2
  1. 1.Department of Applied Health ScienceIndiana University School of Public Health-Bloomington and the Rural Center for AIDS/STD Prevention BloomingtonBloomingtonUSA
  2. 2.College of Pharmacy and Health Sciences, Butler UniversityIndianapolisUSA

Personalised recommendations